NASDAQ · Drug Manufacturers - Specialty & Generic

ANI Pharmaceuticals, Inc. (ANIP) Stock

$71.98 +0.07% NASDAQ: ANIP Healthcare

Valuation

MetricValue
Price$71.98
Market Cap$1.64B
P/E Ratio14.94
P/B Ratio2.56
P/S Ratio1.68
EPS (TTM)$0.00
52-Week High$97.00
52-Week Low$69.58
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE19.19%
ROA7.08%
ROCE12.41%
Gross Margin9.17%
Operating Margin9.17%
Net Margin10.82%
Debt/Equity0.55
Current Ratio2.71

Annual Financials (USD)

Metric20212022202320242025
Revenue$216.0M$316.0M$487.0M$614.0M$883.0M
Operating Profit$-40.0M$-35.0M$47.0M$1.0M$81.0M
Net Profit$-43.0M$-48.0M$19.0M$-19.0M$78.0M
EPS$-3.40$-3.05$0.94$-1.04$3.32
Op Margin-18.4%-11.2%9.7%0.1%9.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$772.0M$760.0M$904.0M$1.3B$1.4B
Total Liabilities$413.0M$422.0M$447.0M$855.0M$900.0M
Cash$100.0M$48.0M$221.0M$145.0M$286.0M
Borrowings$287.0M$287.0M$286.0M$624.0M$325.0M

Latest News

2 Value Stocks for Long-Term Investors and 1 We Avoid StockStory · Jul 10, 2026 ANI Pharmaceuticals CFO Sells $240,000 in Stock After a 42% Cortrophin Surge Motley Fool · Jul 9, 2026 3 of Wall Street’s Favorite Stocks to Target This Week StockStory · Jul 6, 2026 How Is Viatris’ Stock Performance Compared to Other Healthcare Stocks? Barchart · Jun 19, 2026 Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings? Zacks · Jun 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$3.0M$-31.0M$119.0M$64.0M$185.0M
Investing Cash Flow$-129.0M$-32.0M$-37.0M$-422.0M$-69.0M
Financing Cash Flow$1.0M$-1.0M$-8.0M$-79.0M$-12.0M
Net Cash Flow$92.0M$-52.0M$168.0M$-76.0M$141.0M
Free Cash Flow$-20.0M$-48.0M$100.0M$47.0M$151.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA6.30
FCF Yield9.72%
Quick Ratio2.41
Interest Coverage5.47
Return 1Y17.73%
Return 3Y49.19%
Return 5Y137.73%

Ownership

Insiders Held5.55%
Institutions Held110.29%
Institutions Float Held116.77%
Institutional HolderSharesReport Date
Blackrock Inc.2,747,4922026-03-31
Vanguard Capital Management LLC823,0642026-03-31
Soleus Capital Management, L.P.820,2432026-03-31
State Street Corporation771,5872026-03-31
Tang Capital Management, LLC707,5002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMPHAmphastar Pharmaceuticals, Inc. $25.81 +1.06% 14.50 $1.14B 0.00%
AMRXAmneal Pharmaceuticals, Inc. $19.65 +0.00% 36.74 $6.27B 0.00%
BHCBausch Health Companies Inc. $6.04 -1.79% -2.08 $2.26B 0.00%
COLLCollegium Pharmaceutical, Inc. $22.11 +0.82% 14.47 $717.11M 0.00%
EOLSEvolus, Inc. $7.80 +0.78% -14.94 $513.67M 0.00%

About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. (ANIP) stock trades at $71.98 with a market capitalization of $1.64B. The stock is valued at a price-to-earnings (P/E) ratio of 14.94, price-to-book of 2.56, price-to-sales of 1.68. Over the past 52 weeks the stock has ranged between $69.58 and $97.00, and currently trades 25.8% below its 52-week high.

On profitability, ANI Pharmaceuticals, Inc. generates a return on equity (ROE) of 19.19%, above the typical market average, return on capital employed of 12.41%, an operating margin of 9.17%, a net profit margin of 10.82%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides